Tech Company Financing Transactions

RetroSense Therapeutics Funding Round

RetroSense Therapeutics closed a $6 million Series B investment round on 11/16/2015. Backers included BlueWater Angels, ExSight Capital and RBV Capital.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
The financing and support will enable us to move forward more quickly, with broader reach.

Company Information

Company Status
Acquired or Merged
Mailing Address
330 East Liberty Street LL
Ann Arbor, MI 48104
Email Address
Led by a team of seasoned veterans, RetroSense Therapeutics was founded in 2009 to develop a novel gene therapy approach to vision restoration.
RetroSense Therapeutics LinkedIn Company Profile
Social Media
RetroSense Therapeutics Company Twitter Account
Company News
RetroSense Therapeutics News
RetroSense Therapeutics on Facebook
RetroSense Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Sean Ainsworth
  Sean Ainsworth LinkedIn Profile  Sean Ainsworth Twitter Account  Sean Ainsworth News  Sean Ainsworth on Facebook
Chief Medical Officer
Peter Francis
  Peter Francis LinkedIn Profile  Peter Francis Twitter Account  Peter Francis News  Peter Francis on Facebook
Chief Operating Officer
Thomas Rea
  Thomas Rea LinkedIn Profile  Thomas Rea Twitter Account  Thomas Rea News  Thomas Rea on Facebook



Browse more venture capital transactions:

Prev: 11/16/2015: Varentec venture capital transaction
Next: 11/16/2015: The Better Software Company venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We report on every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary